Jefferies has recently initiated Oscar Health Inc (OSCR) stock to Underperform rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 6, 2024, BofA Securities had reduced the stock from a Neutral to Underperform, setting a price target of $13.50 for OSCR stock. UBS also initiated Neutral rating with a price target of $23. Additionally, Piper Sandler initiated Overweight rating on June 26, 2024, with a target price of $25. Robert W. Baird analysts, in their report published on May 30, 2024, also initiated Outperform rating and set a price target of $28 for Oscar Health Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Oscar Health Inc (OSCR) Stock Trading Recap
On Thursday, Oscar Health Inc (OSCR) stock saw a decline, ending the day at $13.06 which represents a decrease of $-0.70 or -5.09% from the prior close of $13.76. The stock opened at $13.76 and touched a low of $12.43 during the day, reaching a high of $13.85. The volume of shares traded was 7.75 million exceeding the average volume of 4.16 million.
Sponsored
OSCR Stock Performance and Moving Averages
In recent trading, Oscar Health Inc (OSCR) stock price has shown some volatility, fluctuating -11.64% over the last five trades and -12.53% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -28.56%, and it has plunged by -5.36% in the previous three months. Currently, OSCR is trading at -16.27%, -13.16%, and -24.82% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, OSCR, a Healthcare sector stock, is trading -45.10% below its 52-week high but remains 0.08% above its 52-week low. The Average True Range (ATR) (14 days) of 1.06 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Oscar Health Inc’s Profitability and Valuation Ratios
Oscar Health Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of 0.62% and a profit margin of 0.28%, with a gross margin of -28.56%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Oscar Health Inc’s market capitalization stands at $3.23 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The forward P/E ratio, which uses projected earnings for the next financial year, is 12.55. Additionally, the Price-to-Sales Ratio is 0.35, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 3.23, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 29.86% of Oscar Health Inc (OSCR)’s shares, while financial institutions hold 69.62%.
Notable insider trades include Quane Alessandrea C., EVP, Chief Insurance Officer at Oscar Health Inc (OSCR), who sold 16793 shares on Dec 06 ’24, at $16.16 each, totaling $0.27 million. On Dec 06 ’24, Blackley Richard Scott, Chief Financial Officer, sold 29939 shares for $16.16 each, amounting to $0.48 million. Additionally, on Dec 02 ’24, Wolin Steven sold 19580 shares at $18.08 each, generating $0.35 million.
